<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">397495714</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180308164520.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">161202e199508  xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1016/S1010-7940(05)80081-8</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)oxford-10.1016/S1010-7940(05)80081-8</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Right ventricular outflow reconstruction with homografts</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Ninety children and young adults underwent right ventricular outflowtract (RVOT) reconstruction with aortic or pulmonary homografts from May,1989 to May, 1994. The patients were divided into three groups according topreoperative diagnosis: RVOT obstructions with ventriculo- arterial (VA)concordance (61), RVOT obstructions with VA discordance (18) and truncusarteriosus (11). Of the reconstructions, 52% were reoperations. A pulmonaryhomograft was used by preference (85% in the concordant group and 33% inthe discordant group). One patient died after homograft correction(hospital mortality 1.1%). The mean follow- up was 32 +/- 22 months. Onepatient died after 10 months due to congestive heart failure andobstructive pulmonary hypertension. All other patients were in NYHA classesI-II. Three patients (two discordant and one truncus correction) underwentreoperation because of aortic homograft dysfunction and calcification. Theincidence of significant (&gt; or = 40 mmHg) gradient across thereconstruction found at the last echocardiographic control was 4% in theconcordant, 28% in the discordant, and 18% in the truncus, group.Echocardiographic evidence of moderate (grade 2-3/4) pulmonaryregurgitation (PR) was noticed in 24 and 13% of the concordant anddiscordant groups, respectively. From this medium-term experience it isconcluded that (1) the medium-term performance of cryopreserved homograftsis excellent, even in young patients, (2) corrections in patients with VAdiscordance need close follow-up, (3) the use of pulmonary homografts,especially in VA concordant lesions, should be encouraged, (4) longer-termfollow- up is necessary to confirm the superiority of the cryopreservedhomograft when compared to the porcine xenograft in the RVOT.</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">European Journal of Cardio-Thoracic Surgery</subfield>
   <subfield code="d">Elsevier Science B.V.</subfield>
   <subfield code="g">9/8(1995-08), 448-451</subfield>
   <subfield code="x">1010-7940</subfield>
   <subfield code="q">9:8&lt;448</subfield>
   <subfield code="1">1995</subfield>
   <subfield code="2">9</subfield>
   <subfield code="o">ejcts</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1016/S1010-7940(05)80081-8</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">abstract</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1016/S1010-7940(05)80081-8</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">European Journal of Cardio-Thoracic Surgery</subfield>
   <subfield code="d">Elsevier Science B.V</subfield>
   <subfield code="g">9/8(1995-08), 448-451</subfield>
   <subfield code="x">1010-7940</subfield>
   <subfield code="q">9:8&lt;448</subfield>
   <subfield code="1">1995</subfield>
   <subfield code="2">9</subfield>
   <subfield code="o">ejcts</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">CC BY-NC-4.0</subfield>
   <subfield code="u">http://creativecommons.org/licenses/by-nc/4.0</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-oxford</subfield>
  </datafield>
 </record>
</collection>
